Arkolith/Insider Trading/DNLI/Form 4

Schenkein David P

DirectorDenali Therapeutics Inc. (DNLI) · full profile →Form 4 · filed Nov 13, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.9M
Net Open-Market Flow
-$1.9M
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 11, 2024Option exercise(M)47K$18.00$849K69K
Nov 11, 2024Sell(S)27K$32.09$871K42K
Nov 11, 2024Sell(S)32K$32.87$1.1M9K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 11, 2024Option exercise(M)47K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001714899-24-000219) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML